Literature DB >> 30531937

NDUFV2 pseudogene (NDUFV2P1) contributes to mitochondrial complex I deficits in schizophrenia.

Oded Bergman1, Rachel Karry1, Jumana Milhem1, Dorit Ben-Shachar2.   

Abstract

Mitochondria together with other cellular components maintain a constant crosstalk, modulating transcriptional and posttranslational processes. We and others demonstrated mitochondrial multifaceted dysfunction in schizophrenia, with aberrant complex I (CoI) as a major cause. Here we show deficits in CoI activity and homeostasis in schizophrenia-derived cell lines. Focusing on a core CoI subunit, NDUFV2, one of the most severely affected subunits in schizophrenia, we observed reduced protein level and functioning, with no change in mRNA transcripts. We further show that NDUFV2 pseudogene (NDUFV2P1) expression is increased in schizophrenia-derived cells and in postmortem brain specimens. In schizophrenia and controls pooled samples, NDUFV2P1 level demonstrated a significant inverse correlation with NDUFV2 pre- and matured protein level and with CoI-driven cellular respiration. Our data suggest a role for a pseudogene in its parent-gene regulation and possibly in CoI dysfunction in schizophrenia. The abnormal expression of the pseudogene may be one element of a vicious circle in which CoI deficits lead to mitochondrial dysfunction potentially affecting genome-wide regulation of gene expression, including the expression of pseudogenes.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30531937     DOI: 10.1038/s41380-018-0309-9

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  71 in total

Review 1.  GABAergic interneuron origin of schizophrenia pathophysiology.

Authors:  Kazu Nakazawa; Veronika Zsiros; Zhihong Jiang; Kazuhito Nakao; Stefan Kolata; Shuqin Zhang; Juan E Belforte
Journal:  Neuropharmacology       Date:  2011-01-26       Impact factor: 5.250

Review 2.  Postmortem studies on mitochondria in schizophrenia.

Authors:  Rosalinda C Roberts
Journal:  Schizophr Res       Date:  2017-02-09       Impact factor: 4.939

Review 3.  Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine.

Authors:  Dorit Ben-Shachar
Journal:  J Neurochem       Date:  2002-12       Impact factor: 5.372

4.  Role of mitochondria and energy metabolism in schizophrenia and psychotic disorders.

Authors:  C Konradi; D Öngür
Journal:  Schizophr Res       Date:  2017-07-10       Impact factor: 4.939

Review 5.  Mitochondrial dysfunction in schizophrenia: pathways, mechanisms and implications.

Authors:  Ashwini Rajasekaran; Ganesan Venkatasubramanian; Michael Berk; Monojit Debnath
Journal:  Neurosci Biobehav Rev       Date:  2014-11-15       Impact factor: 8.989

Review 6.  Mitochondrial multifaceted dysfunction in schizophrenia; complex I as a possible pathological target.

Authors:  Dorit Ben-Shachar
Journal:  Schizophr Res       Date:  2016-10-29       Impact factor: 4.939

Review 7.  Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment.

Authors:  Marc Laruelle; Lawrence S Kegeles; Anissa Abi-Dargham
Journal:  Ann N Y Acad Sci       Date:  2003-11       Impact factor: 5.691

Review 8.  Phosphorus magnetic resonance spectroscopy studies in schizophrenia.

Authors:  Cagri Yuksel; Cuneyt Tegin; Lauren O'Connor; Fei Du; Ezgi Ahat; Bruce M Cohen; Dost Ongur
Journal:  J Psychiatr Res       Date:  2015-06-25       Impact factor: 4.791

Review 9.  Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions.

Authors:  Jim van Os; Bart Pf Rutten; Richie Poulton
Journal:  Schizophr Bull       Date:  2008-09-12       Impact factor: 9.306

10.  Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress.

Authors:  S Prabakaran; J E Swatton; M M Ryan; S J Huffaker; J T-J Huang; J L Griffin; M Wayland; T Freeman; F Dudbridge; K S Lilley; N A Karp; S Hester; D Tkachev; M L Mimmack; R H Yolken; M J Webster; E F Torrey; S Bahn
Journal:  Mol Psychiatry       Date:  2004-07       Impact factor: 15.992

View more
  8 in total

1.  Haloperidol rescues the schizophrenia-like phenotype in adulthood after rotenone administration in neonatal rats.

Authors:  Thiago Garcia Varga; Juan Guilherme de Toledo Simões; Amanda Siena; Elisandra Henrique; Regina Cláudia Barbosa da Silva; Vinicius Dos Santos Bioni; Aline Camargo Ramos; Tatiana Rosado Rosenstock
Journal:  Psychopharmacology (Berl)       Date:  2021-06-05       Impact factor: 4.530

Review 2.  The bimodal mechanism of interaction between dopamine and mitochondria as reflected in Parkinson's disease and in schizophrenia.

Authors:  Dorit Ben-Shachar
Journal:  J Neural Transm (Vienna)       Date:  2019-12-17       Impact factor: 3.575

3.  Complex Analysis of Retroposed Genes' Contribution to Human Genome, Proteome and Transcriptome.

Authors:  Magdalena Regina Kubiak; Michał Wojciech Szcześniak; Izabela Makałowska
Journal:  Genes (Basel)       Date:  2020-05-12       Impact factor: 4.096

4.  Advances in schizophrenia research: glycobiology, white matter abnormalities, and their interactions.

Authors:  Julio Licinio; Ma-Li Wong
Journal:  Mol Psychiatry       Date:  2020-12-03       Impact factor: 15.992

5.  Oxidative Stress Impact on the Transcriptome of Differentiating Neuroblastoma Cells: Implication for Psychiatric Disorders.

Authors:  Behnaz Khavari; Ebrahim Mahmoudi; Michael P Geaghan; Murray J Cairns
Journal:  Int J Mol Sci       Date:  2020-12-02       Impact factor: 5.923

Review 6.  Not So Dead Genes-Retrocopies as Regulators of Their Disease-Related Progenitors and Hosts.

Authors:  Joanna Ciomborowska-Basheer; Klaudia Staszak; Magdalena Regina Kubiak; Izabela Makałowska
Journal:  Cells       Date:  2021-04-15       Impact factor: 6.600

Review 7.  Re-recognition of pseudogenes: From molecular to clinical applications.

Authors:  Xu Chen; Lin Wan; Wei Wang; Wen-Jin Xi; An-Gang Yang; Tao Wang
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

8.  The Relationship between the Level of Anterior Cingulate Cortex Metabolites, Brain-Periphery Redox Imbalance, and the Clinical State of Patients with Schizophrenia and Personality Disorders.

Authors:  Amira Bryll; Wirginia Krzyściak; Paulina Karcz; Natalia Śmierciak; Tamas Kozicz; Justyna Skrzypek; Marta Szwajca; Maciej Pilecki; Tadeusz J Popiela
Journal:  Biomolecules       Date:  2020-09-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.